SR9238 is a potent synthetic LXR antagonist with IC50s of 214 nM and 43 nM for LXRα and LXRβ respectively.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Cell-based cotransfection assays have demonstrated that SR9238 is a synthetic inverse agonist for LXR, with IC50 values of 214 nM for LXRα and 43 nM for LXRβ. SR9238 also effectively inhibits the transcription of a luciferase reporter gene driven by the Fasn promoter. It has been found that SR9238 induces an increase in the interaction of CoRNR box peptides derived from NCoR (NCoR ID1 and NCoR ID2) with LXRα and LXRβ, while decreasing the interaction with coactivator NR box peptides derived from TRAP220. The recruitment of CoRNR box peptides induced by SR9238 is dose-dependent for both LXRα and LXRβ. Treatment of HepG2 cells with SR9238 results in a significant reduction in the expression of Fasn and Srebp1c mRNA[1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.68mL 0.34mL 0.17mL |
8.39mL 1.68mL 0.84mL |
16.79mL 3.36mL 1.68mL |
CAS号 | 1416153-62-2 |
分子式 | C31H33NO7S2 |
分子量 | 595.73 |
SMILES Code | O=C(C1=CC=C(CN(CC2=CC=C(C3=CC=CC(S(=O)(C)=O)=C3)C=C2)S(=O)(C4=C(C)C=C(C)C=C4C)=O)O1)OCC |
MDL No. | MFCD29472591 |
别名 | |
运输 | 蓝冰 |
InChI Key | HDZWHJYZJWLTAG-UHFFFAOYSA-N |
Pubchem ID | 71478195 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|